Saint-Gobain launches T cell-specific cell culture bags

By The Science Advisory Board staff writers

February 26, 2021 -- Saint-Gobain Life Sciences has launched VueLife HP, a new high-permeability cell culture bag designed specifically for T cell-derived therapies.

The product builds on the company's VueLife family of fluorinated ethylene propylene-based cell culture bags. It incorporates a patented laminate film layer that enables increased carbon dioxide and oxygen exchange, compared with other monolayer bag designs, while maintaining the scalability and process flexibility of a closed-bag system, the company said. The increased permeability associated with the laminate layer is intended for culturing cells that require higher rates of respiration, such as T cells.

Saint-Gobain is a material science company that provides solutions for the cell and gene therapy manufacturing industry.

VueLife HP series bag cell culture testing in Saint-Gobain Life Sciences Laboratory
VueLife HP series bag cell culture testing in Saint-Gobain Life Sciences Laboratory. Image courtesy of Saint-Gobain.
New consortium formed to develop cell-based cancer vaccines
A new consortium has been formed to increase access to cell-based cancer vaccines by using single-use technology to develop and manufacture dendritic...

Copyright © 2021

International Society for Cell and Gene Therapy Annual Meeting
May 4 - June 7
San Francisco, California United States
Interphex 2022 Conference
May 24-26
New York, New York United States
American Society for Mass Spectrometry Annual Conference
June 5-9
Minneapolis, Minnesota United States
American Society for Microbiology Microbe Meeting
June 9-13
District of Columbia United States
HPLC 2022
June 18-23
San Diego, California United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter